blog

We are pleased to announce that we have received a grant from the Recovery and Resilience plan of 3 million EUR. It is intended for

Prostate cancer represents growing burden on healthcare systems – direct costs related to its treatment and diagnostics in Slovakia grew by more than 2.5 times

We have accepted an invitation from Slovak television TA3 to discuss prostate cancer, which is one of the most common oncological diseases among men in

We are very pleased that Innovate Slovakia has included us to the list of the most promising and innovative startups to watch in 2024. Success

On Saturday May 25th our team of runners joined forces at the event “Run for Healthy Breasts“, aimed to support the fight against breast cancer

Read the interview we gave to the daily newspaper SME on the topic of early diagnosis of cancer. We are very grateful for all the

Our vision is to create a world where cancer is diagnosed early and treated successfully. We are pleased to announce that we have launched a

It is a great pleasure for us to introduce our Head of Regulatory and Clinical Affairs, who joined Glycanostics in February this year. Zuzana Batova

It was my great pleasure to present Glycanostics® and our early-stage cancer diagnostic test Giasay® at the EIC & EuroQuity – Bpifrance Healthcare Investor Day on 23 October in

„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in

Meet our CEO Eva Kovacova FCCA at the European Angel Investment Summit in Brussels on 10-11 October! Join me at the premier annual conference where angels, entrepreneurs,